Ornament Health AG invests in Genius Labs projects
Investments in health are the most important of our lives. In recent years, preventive medicine, which aims to prevent disease rather than cure it, has become increasingly popular. At the peak of this trend, Ornament Health AG is expanding its possibilities by investing in IT projects allowing people to consciously look after their health.
Key takeaways
- Investments in health are the most important of our lives.
Who this is for
People exploring Ornament blog through blood, medical technology.
Why it matters
This piece helps you get oriented quickly, then move into a collection or series if you want to keep going.
Alina
Continue reading
The Laboratory Inside You: Ornament Invested In The High-tech Startup Spiden
The ambitious project started with an idea that soon the human body and modern medical technology will become one. It will be possible to continuously monitor the body's condition in real-time thanks to the introduction of a next-generation microchip in the blood. Once the realm of science fiction, this is now a near reality.
How Genetically Modified Mosquitoes Will Protect People From Dangerous Diseases
Aedes aegypti mosquitoes live in a tropical climate and carry dangerous diseases such as dengue fever and the Zika virus. Annually, $1 million USD is budgeted to combat malevolent mosquitoes. The new development by the biotech company Oxitec, which has created genetically modified mosquitoes, will cost less and be more effective. This is an important development because mosquitoes become pesticide-resistant over time.
Ornament Will Exchange Data With Apple Health
There is good news for all iPhone owners. The new version of Ornament can be integrated with the Apple Health app. How will it work? And what are the benefits?
Blood Transfusion for Premature Babies: A New Perspective
The largest randomized clinical trial on blood transfusion to premature babies was completed by Dr. Haresh Kirpalani of the University of Pennsylvania, Dr. Edward Bell of the University of Iowa, and colleagues from the Neonatal Research Network, including Dr. Rosemary Higgins of the George Mason University College of Health and Human Services. The study was published in the New England Journal of Medicine. To date, this is the most ambitious research in the world that examines blood transfusion in premature babies.
Install Ornament to not only read these articles, but also track your health, store test results, and access other useful features